NEKTAR THERAPEUTICS - Common Stock, $0.0001 par value (NKTR)

CUSIP: 640268108

Q4 2019 13F Holders as of 31 Dec 2019

Type / Class
Equity / Common Stock, $0.0001 par value
Shares outstanding
29,109,163
Total 13F shares
175,849,330
Share change
-2,811,002
Total reported value
$3,795,370,239
Put/Call ratio
91%
Price per share
$21.58
Number of holders
270
Value change
-$40,913,708
Number of buys
130
Number of sells
148

Security key

640268108

Report period

Q4 2019

Institutions

270

Top holders

10

Top shareholders of NKTR - NEKTAR THERAPEUTICS - Common Stock, $0.0001 par value (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
Invesco Ltd.
13F
Company
119%
34,643,386
$631,029,000 30 Sep 2019
13F
PRIMECAP MANAGEMENT CO/CA/
13F
Company
66%
19,123,222
$348,329,000 30 Sep 2019
13F
VANGUARD GROUP INC
13F
Company
61%
17,828,305
$324,743,000 30 Sep 2019
13F
WELLINGTON MANAGEMENT GROUP LLP
13F
Company
57%
16,500,943
$300,566,000 30 Sep 2019
13F
BlackRock Finance, Inc.
13F
Company
47%
13,558,280
$246,963,000 30 Sep 2019
13F
FMR LLC
13F
Company
45%
13,130,036
$239,163,000 30 Sep 2019
13F
STATE STREET CORP
13F
Company
25%
7,419,493
$135,146,000 30 Sep 2019
13F
Bellevue Group AG
13F
Company
11%
3,172,886
$57,794,000 30 Sep 2019
13F
Camber Capital Management LP
13F
Company
10%
3,000,000
$54,645,000 30 Sep 2019
13F
GEODE CAPITAL MANAGEMENT, LLC
13F
Company
9.7%
2,814,872
$51,198,000 30 Sep 2019
13F
FIRST TRUST ADVISORS LP
13F
Company
9.1%
2,657,141
$48,400,000 30 Sep 2019
13F
NORGES BANK
13F
Company
8.5%
2,482,501
$45,219,000 30 Sep 2019
13F
GREAT POINT PARTNERS LLC
13F
Company
7.3%
2,125,000
$38,707,000 30 Sep 2019
13F
NORTHERN TRUST CORP
13F
Company
6.9%
2,004,571
$36,513,000 30 Sep 2019
13F
JPMORGAN CHASE & CO
13F
Company
5.9%
1,722,279
$31,372,000 30 Sep 2019
13F
FEDERATED HERMES, INC.
13F
Company
5.3%
1,552,100
$28,272,000 30 Sep 2019
13F
Bank of New York Mellon Corp
13F
Company
5.1%
1,485,149
$27,052,000 30 Sep 2019
13F
PRICE T ROWE ASSOCIATES INC /MD/
13F
Company
5%
1,469,308
$26,763,000 30 Sep 2019
13F
JANUS HENDERSON GROUP PLC
13F
Company
5%
1,458,153
$26,560,000 30 Sep 2019
13F
GOLDMAN SACHS GROUP INC
13F
Company
4.4%
1,291,802
$23,531,000 30 Sep 2019
13F
Rhenman & Partners Asset Management AB
13F
Company
4.1%
1,200,000
$21,858,000 30 Sep 2019
13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC
13F
Company
3.6%
1,049,925
$19,125,000 30 Sep 2019
13F
DEUTSCHE BANK AG\
13F
Company
3.6%
1,046,350
$19,055,000 30 Sep 2019
13F
MILLENNIUM MANAGEMENT LLC
13F
Company
3.4%
990,098
$18,034,000 30 Sep 2019
13F
CREDIT SUISSE AG/
13F
Company
2.7%
795,920
$14,497,000 30 Sep 2019
13F
FRONTIER CAPITAL MANAGEMENT CO LLC
13F
Company
2.7%
793,906
$14,461,000 30 Sep 2019
13F
Cormorant Asset Management, LP
13F
Company
2.7%
788,800
$14,368,000 30 Sep 2019
13F
SUSQUEHANNA INTERNATIONAL GROUP, LLP
13F
Company
2.6%
755,135
$13,755,000 30 Sep 2019
13F
Legal & General Group Plc
13F
Company
2.4%
688,364
$12,536,000 30 Sep 2019
13F
Sumitomo Mitsui Trust Group, Inc.
13F
Company
2.3%
677,331
$12,338,000 30 Sep 2019
13F
RICE HALL JAMES & ASSOCIATES, LLC
13F
Company
2.1%
617,674
$11,251,000 30 Sep 2019
13F
TOBAM
13F
Company
2%
583,414
$10,627,000 30 Sep 2019
13F
Swiss National Bank
13F
Company
2%
575,629
$10,485,000 30 Sep 2019
13F
Nuveen Asset Management, LLC
13F
Company
1.8%
537,348
$9,788,000 30 Sep 2019
13F
MORGAN STANLEY
13F
Company
1.7%
504,590
$9,192,000 30 Sep 2019
13F
Artal Group S.A.
13F
Company
1.7%
500,000
$9,108,000 30 Sep 2019
13F
BARCLAYS PLC
13F
Company
1.7%
495,994
$9,033,000 30 Sep 2019
13F
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC
13F
Company
1.6%
470,255
$8,565,697 30 Sep 2019
13F
PARAMETRIC PORTFOLIO ASSOCIATES LLC
13F
Company
1.6%
469,333
$8,549,000 30 Sep 2019
13F
PDT Partners, LLC
13F
Company
1.6%
452,364
$8,240,000 30 Sep 2019
13F
Retirement Systems of Alabama
13F
Company
1.3%
392,772
$7,154,000 30 Sep 2019
13F
WELLS FARGO & COMPANY/MN
13F
Company
1.3%
391,335
$7,128,000 30 Sep 2019
13F
S.c.a. Candriam
13F
Individual
1.3%
390,000
$7,104,000 30 Sep 2019
13F
RHUMBLINE ADVISERS
13F
Company
1.3%
386,890
$7,047,000 30 Sep 2019
13F
OSTERWEIS CAPITAL MANAGEMENT INC
13F
Company
1.3%
374,355
$6,819,000 30 Sep 2019
13F
AustralianSuper Pty Ltd
13F
Company
1.3%
372,895
$6,792,000 30 Sep 2019
13F
BANK OF AMERICA CORP /DE/
13F
Company
1.1%
324,541
$5,911,000 30 Sep 2019
13F
NEW YORK STATE COMMON RETIREMENT FUND
13F
Company
1%
302,600
$5,512,000 30 Sep 2019
13F
BLAIR WILLIAM & CO/IL
13F
Company
0.98%
286,681
$5,222,000 30 Sep 2019
13F
Tekla Capital Management LLC
13F
Company
0.97%
283,679
$5,167,000 30 Sep 2019
13F

Institutional Holders of NEKTAR THERAPEUTICS - Common Stock, $0.0001 par value (NKTR) as of Q4 2019

As of 31 Dec 2019, NEKTAR THERAPEUTICS - Common Stock, $0.0001 par value (NKTR) was held by 270 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 175,849,330 shares. The largest 10 holders included Invesco Ltd., PRIMECAP MANAGEMENT CO/CA/, BlackRock Inc., WELLINGTON MANAGEMENT GROUP LLP, VANGUARD GROUP INC, FMR LLC, STATE STREET CORP, Camber Capital Management LP, Bellevue Group AG, and MAVERICK CAPITAL LTD. This page lists 271 institutional shareholders reporting positions in this security for the Q4 2019 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q4 2019 vs Q3 2019 Across Filers

Q3 2019 holders
272
Q4 2019 holders
270
Holder diff
-2
Investor Q3 2019 Shares Q4 2019 Shares Share Diff Share Chg % Q3 2019 Value $ Q4 2019 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .